SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (1184)12/21/1997 3:11:00 PM
From: Dauntless  Read Replies (2) | Respond to of 7041
 
Thanks for the post - especially this part from near the end -

Some securities analysts speculated themselves that short-sellers
stepped up their aggressive attacks on Zonagen because they were under pressure to repay loans. "It's not a blockbuster drug," Lisi said. "But millions of men may use it, especially if Pfizer's pill doesn't work for them. So this is all slightly unjustified."



To: BigKNY3 who wrote (1184)12/21/1997 4:13:00 PM
From: taxikid  Read Replies (1) | Respond to of 7041
 
do you know what plough's ticker is that may be one to short if they keep dropping cash the way they appered to here..
taxi


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News